New stroke stent tested against standard treatment
NCT ID NCT04973332
Summary
This study tested if a new medical device (the SINOMED SR stent) is as good as an established device (Solitaire FR) for removing blood clots from the brain during a stroke. It involved 218 adults who had a recent stroke and needed emergency treatment. The main goal was to see if the new stent could reopen blocked brain arteries as successfully and safely as the standard option.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBROVASCULAR DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Central Hospital of Xiang Tan city
Xiangtan, China
-
Ganzhou Municipal Hospital
Ganzhou, China
-
Ganzhou People's Hospital
Ganzhou, China
-
General Hospital of Eastern Theater Command, PLA
Nanjing, 210000, China
-
General Hospital of Northern Theater Command, PLA
Shenyang, China
-
Handan Central Hospital
Handan, China
-
Jiangmen Wuyi Hospital of Traditional Chinese Medicine
Jiangmen, China
-
Jinan Central Hospital
Jinan, China
-
Meizhou People's Hospital
Meizhou, China
-
Qingdao Center Hospital
Qingdao, China
-
Taiyuan Central Hospital
Taiyuan, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, China
-
The First Affiliated Hospital of USTC (Anhui Provincial Hospital)
Hehui, China
-
The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital)
Wuhu, China
Conditions
Explore the condition pages connected to this study.